Assessment of pathogenicity criteria for constitutional missense mutations of the hereditary nonpolyposis colorectal cancer genes MLH1 and MSH2

被引:28
作者
Genuardi, M
Carrara, S
Anti, M
de Leòn, MP
Viel, A
机构
[1] Univ Cattolica Sacro Cuore, Ist Genet Med, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, A Gemelli Sch Med, Inst Internal Med & Geriat, Rome, Italy
[3] Univ Modena, Dept Internal Med, I-41100 Modena, Italy
[4] Ctr Riferimento Oncol, Div Expt Oncol 1, I-33081 Aviano, Italy
关键词
mismatch repair; HNPCC; microsatellite instability; mutation; cancer susceptibility;
D O I
10.1038/sj.ejhg.5200363
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To determine the role played by MLH1 and MSH2 missense variants in cancer susceptibility, we have investigated the following genetic and biological characteristics associated with six MLH1 and four MSH2 missense changes identified in Italian hereditary nonpolyposis colorectal cancer (HNPCC) families: co-segregation with disease phenotype and/or bona fide pathogenetic mutations; presence of the variant in healthy control subjects; evolutionary conservation of the involved aminoacid and type of aminoacid change; and presence/absence of microsatellite instability (MSI) in tumour DNA, Overall, nine variants did not fulfil greater than or equal to 2 pathogenicity criteria. MSI was investigated in tumour samples from carriers of nine different missense mutations. Only 3/9 variants were associated with MSI in tumour DNA, In addition, four variants were not present in affected pedigree members, and five variants were observed in the control population. Based upon these results, we conclude that most MLH1 and MSH2 missense changes are unlikely to act as major causative factors in colorectal cancer susceptibility and development.
引用
收藏
页码:778 / 782
页数:5
相关论文
共 30 条
[1]   CLUES TO THE PATHOGENESIS OF FAMILIAL COLORECTAL-CANCER [J].
AALTONEN, LA ;
PELTOMAKI, P ;
LEACH, FS ;
SISTONEN, P ;
PYLKKANEN, L ;
MECKLIN, JP ;
JARVINEN, H ;
POWELL, SM ;
JEN, J ;
HAMILTON, SR ;
PETERSEN, GM ;
KINZLER, KW ;
VOGELSTEIN, B ;
DELACHAPELLE, A .
SCIENCE, 1993, 260 (5109) :812-816
[2]  
Bellacosa A, 1996, AM J MED GENET, V62, P353, DOI 10.1002/(SICI)1096-8628(19960424)62:4<353::AID-AJMG7>3.0.CO
[3]  
2-S
[4]   DETECTION OF NEW MUTATIONS IN 6 OUT OF 10 SWISS HNPCC FAMILIES BY GENOMIC SEQUENCING OF THE HMSH2 AND HMLH1 GENES [J].
BUERSTEDDE, JM ;
ALDAY, P ;
TORHORST, J ;
WEBER, W ;
MULLER, H ;
SCOTT, R .
JOURNAL OF MEDICAL GENETICS, 1995, 32 (11) :909-912
[5]  
Cotton RGH, 1998, HUM MUTAT, V12, P1, DOI 10.1002/(SICI)1098-1004(1998)12:1<1::AID-HUMU1>3.0.CO
[6]  
2-M
[7]   APPLICATION OF NATURAL AND AMPLIFICATION CREATED RESTRICTION SITES FOR THE DIAGNOSIS OF PKU MUTATIONS [J].
EIKEN, HG ;
ODLAND, E ;
BOMAN, H ;
SKJELKVALE, L ;
ENGEBRETSEN, LF ;
APOLD, J .
NUCLEIC ACIDS RESEARCH, 1991, 19 (07) :1427-1430
[8]  
Genuardi M, 1998, INT J CANCER, V75, P835, DOI 10.1002/(SICI)1097-0215(19980316)75:6<835::AID-IJC4>3.0.CO
[9]  
2-W
[10]  
Kowalski LD, 1997, GENE CHROMOSOME CANC, V18, P219, DOI 10.1002/(SICI)1098-2264(199703)18:3<219::AID-GCC8>3.0.CO